Special Issue "Drug Discovery Tools"
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (15 February 2011)
Dr. Andreas Vogt
Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA
Interests: drug discovery, high-content screening, zebrafish, cancer, phosphatases
Over the last two decades, drug discovery has evolved into a science of its own. Advances in genomics, proteomics, chemical library synthesis, and assay technologies have firmly established high-throughput screening in both industry and academia. This special issue captures and highlights advances, successes, and challenges of contemporary drug discovery. We invite articles on all aspects of drug discovery tool development and utilization, including but not limited to, assay technologies, assay design and optimization, model systems (yeast, cells, worms, flies, zebrafish), biosensors, molecular modeling, and virtual screening.
- assay technologies
- high-throughput screening
- high-content analysis
- model systems
- molecular modeling
- virtual screening
Pharmaceutics 2011, 3(2), 186-228; doi:10.3390/pharmaceutics3020186
Received: 17 February 2011; in revised form: 1 April 2011 / Accepted: 19 April 2011 / Published: 21 April 2011| Cited by 4 | PDF Full-text (1040 KB) | HTML Full-text | XML Full-text
Pharmaceutics 2011, 3(2), 141-170; doi:10.3390/pharmaceutics3020141
Received: 14 February 2011; in revised form: 21 March 2011 / Accepted: 31 March 2011 / Published: 4 April 2011| Cited by 8 | PDF Full-text (2094 KB) | HTML Full-text | XML Full-text
Pharmaceutics 2011, 3(1), 107-124; doi:10.3390/pharmaceutics3010107
Received: 14 February 2011; in revised form: 3 March 2011 / Accepted: 10 March 2011 / Published: 11 March 2011| Cited by 16 | PDF Full-text (832 KB) | HTML Full-text | XML Full-text
Last update: 4 March 2014